PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH LENVATINIB

Sacco, R; Ciruolo, M; Paolillo, R; Ramai, D; Tortora, R; Di Costanzo, GG; Burlone, ME; Pirisi, M; Federico, P; Daniele, B; Silletta, M; Gallo, P; Cocuzza, C; Russello, M; Cabibbo, G; Cesario, S; Masi, G; Marzi, L; Mega, A; Granito, A; Pieri, G; Giannini, E; Gadaleta-Caldarola, G; Dadduzio, ; Giordano, G; Giacomelli, L; Papa, S; Renzulli, M; Maida, M; Ghidini, M; Facciorusso, A

DIGESTIVE AND LIVER DISEASE, 2023; 55 (): S119